Meyka Pro banner
Earnings Recap

Rentokil (LON: RTO) Plunges 17% Despite Q2 Earnings Beat as Slowing U.S. Pest Demand Weighs on Outlook

July 30, 2026
05:56 PM
4 min read

Key Points

Rentokil shares plunged 17% despite beating Q2 profit estimates of $459 million.

Core North America Pest Control Services growth slowed sharply to 2.4% in Q2.

Rentokil scrapped its 2027 target for a 20% North American operating margin.

Rival Rollins posted stronger 5.7% organic growth in the same quarter.

Be the first to rate this article

Rentokil Initial shares plunged 17.1% on Thursday, July 30, 2026, despite beating quarterly profit estimates. Shares fell to 367.5 pence, their lowest level since September 29, 2025. The pest control giant reported second-quarter adjusted profit before tax of $459 million, ahead of the $442.7 million consensus. 

Yet weakening North American residential demand overshadowed the beat entirely. Rentokil also scrapped its 2027 target of a 20% North American operating margin.

Rentokil Results Beat Estimates But Miss on Growth

Rentokil’s (NYSE: RTO) headline numbers actually looked solid on the surface for the first half of 2026. Group revenue rose 6.7% to $3.589 billion, slightly above the $3.56 billion analyst forecast.

  • Total Group organic growth rose to 3.8% in Q2, up from 3.4% in Q1.
  • International Pest Control organic growth accelerated to 5.4%, up from 2.8% in Q1.

Free cash flow rose 12.8% to $318 million, with cash conversion improving to 96% from 93%. Net debt fell sharply to $3.6 billion, down from $4.2 billion a year earlier.

Why North America Is Dragging Down Sentiment

North America remains Rentokil’s largest market, generating roughly 59% of total group revenue. Total North America organic growth eased to 3.7% for H1, with Q2 alone at 3.6%, down from 3.9% in Q1.

  • Core North America Pest Control Services organic growth slowed sharply to 2.4% in Q2, down from 2.8% in Q1.
  • Residential customer leads softened toward the end of Q2 and into July.
  • Commercial pest control revenue in North America was particularly weak this quarter.

That deceleration in core North America Pest Control Services, well below company guidance, was the real driver behind Thursday’s selloff. New CEO Mike Duffy, four months into his role, admitted Rentokil isn’t “adequately benefiting from our scale.” That comment referenced the company’s multi-billion-pound Terminix acquisition, completed back in 2022.

Rentokil Scraps Key Margin Target

Rentokil dropped its long-standing target of reaching a 20% North American operating margin by 2027. Duffy said the company will now prioritize volume growth over short-term margin expansion instead.

  • Management plans to simplify operations across the 90 countries where Rentokil operates.
  • Cost savings from branch standardization will get reinvested directly into North America.

The UK business also struggled, citing “softness in overall housing demand” that hurt its asbestos removal unit. Despite these challenges, Rentokil maintained its full-year 2026 guidance in line with market expectations.

Termite Claims and Dividend Growth Continue

Rentokil recorded an additional $47 million provision for termite damage claims during the quarter. That brings its estimated 2026 cash outflow for these claims to $115 million to $125 million.

Despite the earnings selloff, Rentokil raised its interim dividend 8% to 4.48 cents per share. Customer retention improved 90 basis points year-over-year to 86.1%, a modest but positive signal. Full-year guidance still targets roughly $7.3 billion in revenue and $972 million in adjusted profit before tax.

How Rentokil Compares to Rivals

Rentokil’s North American struggles look worse next to competitor Rollins Inc (NYSE: ROL). Rollins posted organic growth of approximately 5.7% for the same second quarter of 2026. Deutsche Bank had rated Rentokil a Hold with a 465p target ahead of this report. Jefferies called the results “encouraging” but said investors will stay focused on the U.S. pest demand trajectory going forward.

Final Thoughts

Rentokil’s 17% drop shows investors care more about core North America growth trends than headline profit beats. With guidance intact and cash flow improving, the selloff may reflect overcorrection rather than a structural collapse.

Disclaimer:

The content shared by Meyka AI PTY LTD is for research and informational purposes only. Meyka is not a financial advisory service, and the information provided should not be treated as investment or trading advice.

What brings you to Meyka?

Pick what interests you most and we will get you started.

I'm here to read news

Find more articles like this one

I'm here to research stocks

Ask Meyka Analyst about any stock

I'm here to track my Portfolio

Get daily updates and alerts (coming March 2026)